内容发布更新时间 : 2024/5/17 8:49:05星期一 下面是文章的全部内容请认真阅读。

[292] Chen YY, Perera DS, Yan TD, et al. Applying Fong\CRS liver score in patients with colorectal liver

metastases treated by cryotherapy. Asian J Surg, 2006, 29: 238-241.

[293] Seifert JK, Junginger T. Cryotherapy for liver tumors: current status, perspectives, clinical results, and

review of literature. Technol Cancer Res Treat, 2004, 3: 151-163.

[294] Gignoux BM, Ducerf C, Mabrut JY, et al. Cryosurgery of primary and metastatic cancers of the liver. Ann

Chir, 2001, 126: 950-959.

[295] Austin-Seymour MM, Chen GT, Castro JR, et al. Dose volume histogram analysis of liver radiation

tolerance. Int J Radiat Oncol Biol Phys, 1986, 12: 31-35.

[296] Eble MJ, Gademann G, Wannenmacher M, et al. The value of radiotherapy for liver metastases. Strahlenther

Onkol, 1993, 169: 459-468.

[297] Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body

radiation therapy for liver metastases. J Clin Oncol, 2009, 27: 1572-1578.

[298] Ingold JA, Reed GB, Kaplan HS, et al. Radiation Hepatitis. Am J Roentgenol Radium Ther Nucl Med, 1965,

93: 200-208.

[299] Yeo SG, Kim DY, Kim TH, et al. Whole-liver radiotherapy for end-stage colorectal cancer patients with

massive liver metastases and advanced hepatic dysfunction. Radiat Oncol, 2010, 5: 97.

[300] Mohiuddin M, Chen E, Ahmad N. Combined liver radiation and chemotherapy for palliation of hepatic

metastases from colorectal cancer. J Clin Oncol, 1996, 14: 722-728.

[301] Robertson JM, McGinn CJ, Walker S, et al. A phase l trial of hepatic arterial bromodeoxyuridine and

conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. J Rad Oncol Biol Phys, 1997, 39: 1087-1092.

[302] Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver

metastases. J Clin Oncol, 2009, 27: 1585-1591.

[303] Goodman KA, Wiegner EA, Maturen KE, et al. Dose-escalation study of single-fraction stereotactic body

radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys, 2010, 78: 486-493.

[304] Milano MT, Katz AW, Zhang H, et al. Oligometastases treated with stereotactic body radiotherapy:

long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys, 2012, 83: 878-886.

[305] Chang DT, Swaminath A, Kozak M, et al. Stereotactic body radiotherapy for colorectal liver metastases: a

pooled analysis. Cancer, 2011, 117: 4060-4069.

[306] Schefter TE, Kavanagh BD, Timmerman RD, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys, 2005, 62: 1371-1378.

[307] Katz AW, Carey-Sampson M, Muhs AG, et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys, 2007, 67: 793-798.